Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Zhiguo Wang

Market Cap

5.92 Thousand USD

Sector

Consumer Defensive

Website

https://www.yewbiopharm.com

Description

Yew Bio-Pharm Group, Inc.

Read More

Overview

Value

26

Growth

29

Health

41

Management

12

Analyst Opinion

63

Total

34

All Scores Out Of 100

Best Features

  • Has a low level of debt
  • Has a history of share buybacks
  • Price-to-earnings ratio of 0.0 is lower than the market average (19.6x)
  • Low preportion of income is paid as dividend

Risk Factors

  • Earnings growth has slowed down recently
  • Income is not covering expenditure and investment
  • Earnings are negative
  • No margin of safety at their current market price
  • Poor earnings and cashflow growth
  • Accounting anomalies: Growing revenues without a corresponding growth in cash flows.
  • 0

Market Peers

YEWB

Key Figures

PE Ratio (TTM)

0.01

Margin Of Safety (DCF)

-139214.94%

Revenue Growth (5 Year Average)

9.13%

Ratings Consensus

Neutral

Share Buybacks

0.02%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

26

  • Price-to-earnings ratio of 0.0 is lower than the market average (19.6x)
  • Estimated intrinsic-value of NaN undefined USD is lower than current price ( 100.00 undefined USD)
  • Free-cashflow-yeild of -118378.25% is worse than the market average (4.7%)
  • Margin-of-safety of -139214.94% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 0.3 USD

Current Price: 0 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

0.01x

Free Cashflow Yeild

-118378.25%

PE/Earnings Growth

N/A

Price/Book

0.00x

Growth

Growth Score

29

  • Revenue growth has improved this yeara
  • 5 Year Average Earnings growth of 25.21% is higher than the market average (14.48%)
  • Free Cashflow growth has improved this year
  • 5 Year Average Revenue growth of 9.13% is lower than the market average (10.97%)
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of -24.58% is lower than the market average (12.35%)

Revenue Growth

9.13%

Earnings Growth

25.21%

Cashflow Growth

-24.58%

Health

Health Score

41

  • Has a low level of debt
  • Assets cover liabilities
  • Normal operation does not require debt to be sustainable
  • Cashflow is negative
  • Debt repayments significantly impact cashflow

Altman Z Score

1.64

Piostroski Score

5.00

Debt/Equity

0.20x

Current Assets/Liabilities

1.11x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

0.68x

Management

Management Score

12

  • Has a history of returning value to shareholders through stock buybacks
  • Return-on-capital-employed of -0.59% is lower than the market average (10%)
  • Has repurchased shares when overvalued
  • Return-on-equity of -3.79% is lower than the market average (15%)

Average Buybacks/Dilution

0.02%

Recent Buybacks/Dilution

14.48%

5 Year Price Volitility

49.10%

Return On Assets

-3.74%

Return On Capital Employed

-0.59%

Return On Equity

-3.79%

Return On Free Cashflow

-98.18%

Return On Investments

N/A

Analysts

Analyst Opinion

63

  • Ratings consensus is Neutral

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Currency

USD

Beta

Vol Avg

Ceo

Mr. Zhiguo Wang

Cik

0001548240

Cusip

98584C101

Exchange

Other OTC

Full Time Employees

Industry

Farm Products

Sector

Consumer Defensive

Ipo Date

Address

9460 Telstar Avenue

City

El Monte

State

CA

Country

Zip

91731

Phone

626 401 9588

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies